Concentric by ginkgo and illumina collaborate to deploy biosurveillance technologies around the world

The companies plan to join forces to set up pathogen monitoring programs utilizing illumina technology across concentric's global network  boston and san diego , jan. 15, 2024 /prnewswire/ -- concentric by ginkgo, the biosecurity and public health unit of ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, today announced that it has entered into a co-marketing agreement with illumina, inc. (nasdaq: ilmn), a global leader in dna sequencing and array-based technologies, to partner on expanding biosecurity capabilities globally. concentric is building a global pathogen monitoring network—a "bioradar" system —in countries around the world to detect, characterize, and rapidly respond to biological threats and help drive informed decision-making in support of global health objectives.
DNA Ratings Summary
DNA Quant Ranking